Inhibition of mTORC2/Akt signaling to enhance the therapeutic potential of CD8 T cells

Inhibition of mTORC2/Akt signaling to enhance the therapeutic potential of CD8 T cells

Bibliographic Details
Main Authors:	Zhang, Lianjun, Tschumi, Benjamin, Oberle, Susanne, Ruegg, Markus, Hall, Michael, Zehn, Dietmar, Mach, Jean-Pierre, Donda, Alena, Romero, Pedro
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649477/

Similar Items

Tumor targeting of innate and adaptive immunity by the adoptive cell transfer of engineered T lymphocytes co-expressing iNKT and tumor-specific MHC-I TCRs
by: Tschumi, Benjamin O, et al.
Published: (2014)

mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation
by: Ding, Xiaolei, et al.
Published: (2016)

In vivo evidence for mTORC2-mediated actin cytoskeleton rearrangement in neurons
by: Angliker, Nico, et al.
Published: (2013)

CART cells are prone to Fas- and DR5-mediated cell death
by: Benjamin O. Tschumi, et al.
Published: (2018-07-01)

iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine
by: Corgnac, Stéphanie, et al.
Published: (2014)

Glutaminolysis feeds mTORC1
by: Durán, Raúl V., et al.
Published: (2012)

GILZ inhibits the mTORC2/AKT pathway in BCR-ABL+ cells
by: Joha, S, et al.
Published: (2012)

Dynamic Adipocyte Phosphoproteome Reveals that Akt Directly Regulates mTORC2
by: Humphrey, Sean J., et al.
Published: (2013)

Role of AKT/mTORC1 pathway in pancreatic β-cell proliferation.
by: Balcazar Morales, Norman, et al.
Published: (2012)

SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt
by: Meng, Haitao, et al.
Published: (2013)

mTORC1 is necessary but mTORC2 and GSK3β are inhibitory for AKT3-induced axon regeneration in the central nervous system
by: Miao, Linqing, et al.
Published: (2016)

RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes
by: Weinberg, Mark A.
Published: (2016)

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
by: Davis, Nicole M., et al.
Published: (2014)

mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases
by: Hannah E. Walters, et al.
Published: (2018-08-01)

Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular model
by: Salama, Mohamed, et al.
Published: (2018)

Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2
by: Luo, Yan, et al.
Published: (2015)

Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion
by: Chen, Long, et al.
Published: (2015)

Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism
by: Guridi, Maitea, et al.
Published: (2016)

mTORC2 sustains thermogenesis via Akt‐induced glucose uptake and glycolysis in brown adipose tissue
by: Albert, Verena, et al.
Published: (2016)

Differential response of skeletal muscles to mTORC1 signaling during atrophy and hypertrophy
by: Bentzinger, C Florian, et al.
Published: (2013)

WNT7B Promotes Bone Formation in part through mTORC1
by: Chen, Jianquan, et al.
Published: (2014)

Regulation of TFEB and V-ATPases by mTORC1
by: Peña-Llopis, Samuel, et al.
Published: (2011)

Regulation of mTORC1 Signaling by pH
by: Balgi, Aruna D., et al.
Published: (2011)

PLD gives nutritional advice to mTORC1
by: Short, Ben
Published: (2011)

Turning acne on/off via mTORC1
by: Danby, F William
Published: (2013)

mTORC1 signaling in hepatic lipid metabolism
by: Jinbo Han, et al.
Published: (2017-04-01)

Regulation of mTORC1 by lysosomal calcium and calmodulin
by: Li, Ruo-Jing, et al.
Published: (2016)

mTORC1 sustains vision in retinitis pigmentosa
by: Petit, Lolita, et al.
Published: (2015)

mTORC2 tips the balance in cell survival
by: Sedwick, Caitlin
Published: (2015)

mTORC2 takes the longevity stAGE
by: Lamming, Dudley W.
Published: (2014)

c-FLIP links mTORC2 to apoptosis
by: Zhao, Liqun, et al.
Published: (2014)

Differential regulation of mTORC1 by leucine and glutamine
by: Jewell, Jenna L., et al.
Published: (2015)

An expanded role for mTORC1 in autophagy
by: Kim, Young-Mi, et al.
Published: (2015)

Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology
by: Thomanetz, Venus, et al.
Published: (2013)

Perspectives of Targeting mTORC1–S6K1 in Cardiovascular Aging
by: Ming, Xiu-Fen, et al.
Published: (2012)

CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses
by: Corgnac, Stéphanie, et al.
Published: (2012)

Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability
by: Pajvani, Utpal B., et al.
Published: (2013)

Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signaling to suppress tumorigenesis
by: Liu, Pengda, et al.
Published: (2013)

mTORC2 Phosphorylation of Akt1: A Possible Mechanism for Hydrogen Sulfide-Induced Cardioprotection
by: Zhou, Yue, et al.
Published: (2014)

Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells
by: Sun, Y, et al.
Published: (2014)